- Home
- VAC vs NKTR Comparison
VAC vs NKTR Comparison
Compare VAC & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VAC | NKTR |
|---|---|---|
| Founded | 1984 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.1B |
| IPO Year | 2011 | 1996 |
Fundamental Metrics
Financial Performance| Metric | VAC | NKTR |
|---|---|---|
| Price | $70.22 | $72.67 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 6 |
| Target Price | $75.38 | ★ $142.00 |
| AVG Volume (30 Days) | 650.5K | ★ 806.5K |
| Earning Date | 05-06-2026 | 03-12-2026 |
| Dividend Yield | ★ 4.71% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $5,032,000,000.00 | $307,711,000.00 |
| Revenue This Year | $54.41 | N/A |
| Revenue Next Year | $2.06 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 1.31 | ★ 86.00 |
| 52 Week Low | $44.58 | $0.43 |
| 52 Week High | $86.33 | $77.00 |
Technical Indicators
Market Signals| Indicator | VAC | NKTR |
|---|---|---|
| Relative Strength Index (RSI) | 60.45 | 58.89 |
| Support Level | $63.77 | $52.99 |
| Resistance Level | $73.13 | $75.96 |
| Average True Range (ATR) | 2.63 | 3.73 |
| MACD | -0.01 | -0.75 |
| Stochastic Oscillator | 71.95 | 64.68 |
Price Performance
Historical ComparisonAbout VAC Marriott Vacations Worldwide Corporation
Marriott Vacations Worldwide Corp functions in the United States leisure industry. It owns and manages a cluster of resorts and accommodation facilities under trademarks like Marriott Vacation Club, Grand Residencies, and The Ritz-Carlton Destination Club predominantly in the United States. Some of its properties are also spread across Europe and Asia Pacific. Marriott's majority revenue components include the sale of vacation ownership products such as luxurious vacation packages. In addition, it offers purchase money financing to the end users of its core services. The company operates in two reportable segments: Vacation Ownership and Exchange & Third-Party Management. The majority of revenue is derived from the Vacation Ownership segment.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.